BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 8081387)

  • 1. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
    Abernathy CR; Colman SD; Kousseff BG; Wallace MR
    Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene.
    Böddrich A; Griesser J; Horn D; Kaufmann D; Krone W; Nürnberg P
    Biochem Biophys Res Commun; 1995 Sep; 214(3):895-904. PubMed ID: 7575561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of NF1 gene mutations in neurofibromatosis type 1 patients in Japan.
    Hatta N; Horiuchi T; Fujita S
    Biochem Biophys Res Commun; 1994 Feb; 199(1):207-12. PubMed ID: 8123014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel insertional mutation of a single base in exon 34 of the neurofibromatosis-1 gene.
    Purandare SM; Davidson HR; Lanyon WG; Connor JM
    Hum Mutat; 1994; 3(1):76-8. PubMed ID: 8118468
    [No Abstract]   [Full Text] [Related]  

  • 5. NF1 mutation analysis using a combined heteroduplex/SSCP approach.
    Abernathy CR; Rasmussen SA; Stalker HJ; Zori R; Driscoll DJ; Williams CA; Kousseff BG; Wallace MR
    Hum Mutat; 1997; 9(6):548-54. PubMed ID: 9195229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects.
    Messiaen LM; Callens T; Mortier G; Beysen D; Vandenbroucke I; Van Roy N; Speleman F; Paepe AD
    Hum Mutat; 2000; 15(6):541-55. PubMed ID: 10862084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of neurofibromatosis type 1 mutations.
    Weiming X; Yu Q; Lizhi L; Ponder M; Wallace M; Gangfeng X; Ponder B
    Hum Mutat; 1992; 1(6):474-7. PubMed ID: 1301957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; neurofibromatosis type 1].
    de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.
    Andersen LB; Fountain JW; Gutmann DH; Tarlé SA; Glover TW; Dracopoli NC; Housman DE; Collins FS
    Nat Genet; 1993 Feb; 3(2):118-21. PubMed ID: 8499944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
    Sawada S; Florell S; Purandare SM; Ota M; Stephens K; Viskochil D
    Nat Genet; 1996 Sep; 14(1):110-2. PubMed ID: 8782831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of neurofibromatosis type I gene product as an insoluble GTPase-activating protein toward ras p21.
    Hattori S; Maekawa M; Nakamura S
    Oncogene; 1992 Mar; 7(3):481-5. PubMed ID: 1549362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of six mutations in exon 37 of neurofibromatosis type 1 gene.
    Upadhyaya M; Osborn M; Maynard J; Harper P
    Am J Med Genet; 1996 Jul; 67(4):421-3. PubMed ID: 8837715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
    Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
    Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
    Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
    Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three different premature stop codons lead to skipping of exon 7 in neurofibromatosis type I patients.
    Wimmer K; Eckart M; Stadler PF; Rehder H; Fonatsch C
    Hum Mutat; 2000 Jul; 16(1):90-1. PubMed ID: 10874316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New evidence for a mutation hotspot in exon 37 of the NF1 gene.
    Böddrich A; Robinson PN; Schülke M; Buske A; Tinschert S; Nürnberg P
    Hum Mutat; 1997; 9(4):374-7. PubMed ID: 9101303
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
    Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1.
    Nyström AM; Ekvall S; Allanson J; Edeby C; Elinder M; Holmström G; Bondeson ML; Annerén G
    Clin Genet; 2009 Dec; 76(6):524-34. PubMed ID: 19845691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF1 gene mutations in Japanese with neurofibromatosis 1 (NF1).
    Hatta N; Horiuchi T; Watanabe I; Kobayashi Y; Shirakata Y; Ohtsuka H; Minami T; Ueda K; Kokoroishi T; Fujita S
    Biochem Biophys Res Commun; 1995 Jul; 212(2):697-704. PubMed ID: 7542886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.